IAEA COVID-19 project draws more than $28 million in funding
A health worker at the IAEA Seibersdorf Laboratories in Austria packs a COVID-19 support equipment package, which includes personal protective equipment, PCR machines, reagents, and laboratory consumables. Photo: D. Calma/IAEA
An initiative by the International Atomic Energy Agency to help nearly 120 countries contain the COVID-19 pandemic has received a financial boost from member states and Takeda Pharmaceutical Company Limited.
The IAEA announced on May 13 that Takeda, a biopharmaceutical company based in Tokyo, donated 500 million yen (about US$4.7 million). Two days earlier, the IAEA announced that pledges from more than 10 member nations totaled €22 million (about US$23.8 million).


ANS’s first Virtual Trivia Night drew over 80 contestants who were ready to test their nuclear knowledge during an evening of Zoom-based socialization sponsored by the ANS Young Members Group, the Student Sections Committee, and the Diversity and Inclusion in ANS Committee. YMG Vice Chair Catherine Prat hosted the May 8 event. “I really appreciated seeing how engaged the players were throughout the night,” she said. “They were great guinea pigs for this first-of-a-kind event, as we continue to explore ways to connect virtually.”
The ANS Young Members Group (YMG) is delivering an in-depth look at the Department of Energy’s national laboratories through a series of live webinars called Spotlight on National Labs. The third and most recent webinar attracted more than 1,000 participants who were keen to learn about the mission and key projects of Los Alamos National Laboratory.